NCT06660069View on ClinicalTrials.gov

A Study to Evaluate the Efficacy of a Stannous Fluoride Toothpaste With a Cetylpyridinium Chloride Mouthwash in Improving Gingival Health and Reducing Plaque Accumulation

NACompletedINTERVENTIONAL
Enrollment

195

Participants

Timeline

Start Date

November 18, 2024

Primary Completion Date

March 11, 2025

Study Completion Date

March 11, 2025

Conditions
Dental PlaqueGingivitis
Interventions
DRUG

Stannous Fluoride Toothpaste (Parodontax Complete Protection Toothpaste)

Toothpaste containing 0.454 percent (%) weight by weight (w/w) SnF2.

DRUG

CPC Mouthwash (Parodontax Active Gum Health Mouthwash)

Mouthwash containing 0.07% w/w CPC.

DRUG

Regular Fluoride Toothpaste (Crest Cavity Protection)

Toothpaste containing 0.243% w/w sodium fluoride.

DRUG

Stannous Fluoride Toothpaste (Parodontax Complete Protection Toothpaste)

Toothpaste containing 0.454% w/w SnF2.

Trial Locations (1)

46825

Salus Research, Fort Wayne

All Listed Sponsors
lead

HALEON

INDUSTRY

NCT06660069 - A Study to Evaluate the Efficacy of a Stannous Fluoride Toothpaste With a Cetylpyridinium Chloride Mouthwash in Improving Gingival Health and Reducing Plaque Accumulation | Biotech Hunter | Biotech Hunter